Assessment of 10-Year Major Osteoporotic and Femur Fracture Risk of Postmenopausal Women Using FRAX®

dc.contributor.authorDemir, Ayse
dc.contributor.authorKutlu, Ruhusen
dc.contributor.authorCivi, Selma
dc.date.accessioned2024-02-23T14:41:15Z
dc.date.available2024-02-23T14:41:15Z
dc.date.issued2014
dc.departmentNEÜen_US
dc.description.abstractObjective: The aim of this study is to assess osteoporosis (OP) risk factors in postmenopausal women and 10-year major osteoporosis and femur facture risks using the World Health Organization's fracture risk assessment scale (FRAX (R)). Material and Methods: This cross-sectional analytic study was carried out on 340 postmenopausal women. Considering participant risk factors and bone mineral densities and using the FRAX (R) risk assessment scale, their 10-year major osteoporotic and femur fracture was assessed. Results: The mean age of the women in our study was 57.5+/-7.8. Of the participants, 47 (13.8%) were osteoporotic, 177 (52.1%) were osteopenic, and 116 (34.1%) were normal. As age increased, OP frequency increased (p<0.001), and as body mass index (BMI) increased, OP frequency decreased (p<0.001). Considering OP existence, there was a statistically significant relation between major OP risk and femur fracture risk, calculated using BMD and without using BMD (p<0.001). Major OP fracture risk, calculated using BMD, was low in 94.7% of the subjects, mild in 5.0%, and high in 0.3%. When osteoporosis risk factors were assessed, while OP frequency in those with 2 or fewer clinical risk factors (CRFs) was 12.8%, OP frequency was 28.0% in those with 3 or 4 risk factors. Conclusion: In this study, it was determined that the FRAX (R) risk assessment scale, which is used to assess 10-year OP fracture risk, is a significant, cost-efficient, easy-to-use assessment criterion whether BDM is applied or not.en_US
dc.description.sponsorshipSelcuk University, Scientific Projects Research Coordination (BAP)en_US
dc.description.sponsorshipThis work was financially supported by Selcuk University, Scientific Projects Research Coordination (BAP). We wish to thank the participating women for their valuable collaboration and kindness.en_US
dc.identifier.doi10.5152/tftrd.2014.78736
dc.identifier.endpageS18en_US
dc.identifier.issn1302-0234
dc.identifier.issn1308-6316
dc.identifier.scopus2-s2.0-84903783888en_US
dc.identifier.startpageS11en_US
dc.identifier.urihttps://doi.org/10.5152/tftrd.2014.78736
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16758
dc.identifier.volume60en_US
dc.identifier.wosWOS:000343521300002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherBaycinar Medical Publ-Baycinar Tibbi Yayinciliken_US
dc.relation.ispartofTurkiye Fiziksel Tip Ve Rehabilitasyon Dergisi-Turkish Journal Of Physical Medicine And Rehabilitationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectOsteoporosisen_US
dc.subjectPostmenopausal Womanen_US
dc.subjectClinical Risk Factorsen_US
dc.subjectFrax (R)en_US
dc.titleAssessment of 10-Year Major Osteoporotic and Femur Fracture Risk of Postmenopausal Women Using FRAX®en_US
dc.typeArticleen_US

Dosyalar